149 related articles for article (PubMed ID: 5282618)
21. [On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
Stier HW; Gallmeier WM; Schmidt CG
Dtsch Med Wochenschr; 1969 Feb; 94(6):253-60. PubMed ID: 5249235
[No Abstract] [Full Text] [Related]
22. Comparison of crystalline and amorphous asparaginase in treatment of acute leukemia in children.
Pratt CB; Verzosa M
Clin Pharmacol Ther; 1972; 13(3):343-8. PubMed ID: 4554659
[No Abstract] [Full Text] [Related]
23. [Blood coagulation disorder due to asparaginase].
De Rossi G; Conti G; DeLuca AM; Monarca B; Tribalto M
Haematologica; 1971; 56(9):420-9. PubMed ID: 5004542
[No Abstract] [Full Text] [Related]
24. [Proceedings: Blood coagulation disorders in the pediatric age. Introduction].
Grasso E
Minerva Pediatr; 1973 Nov; 25(41):1829-32. PubMed ID: 4774584
[No Abstract] [Full Text] [Related]
25. Response to highly purified L-asparaginase during therapy of acute leukemia.
Hill JM; Loeb E; MacLellan A; Khan A; Roberts J; Shields WF; Hill NO
Cancer Res; 1969 Aug; 29(8):1574-80. PubMed ID: 4896902
[No Abstract] [Full Text] [Related]
26. [L-Asparaginase in the treatment of acute leukemia].
Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
[No Abstract] [Full Text] [Related]
27. L-asparaginase-induced coagulation abnormalities: report of a case.
Hensley MF
J Am Osteopath Assoc; 1983 May; 82(9):680-1. PubMed ID: 6575006
[No Abstract] [Full Text] [Related]
28. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
Pui CH; Jackson CW; Chesney C; Lyles SA; Bowman WP; Abromowitch M; Simone JV
J Clin Oncol; 1983 Jun; 1(6):380-5. PubMed ID: 6583320
[TBL] [Abstract][Full Text] [Related]
29. [Hemostatic disorders in the treatment of leukoblastosis with L-asparaginase (crasnitin)].
Genova V
Vutr Boles; 1973; 12(2):43-9. PubMed ID: 4268271
[No Abstract] [Full Text] [Related]
30. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
[No Abstract] [Full Text] [Related]
31. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
de Vaan GA; Marcar JR; Schretlen ED
Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
[No Abstract] [Full Text] [Related]
32. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.
Nowak-Göttl U; Rath B; Binder M; Hassel JU; Wolff J; Husemann S; Ritter J
Haematologica; 1995; 80(5):451-3. PubMed ID: 8566890
[TBL] [Abstract][Full Text] [Related]
33. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
34. Phenobarbital-induced coagulation defects in cats.
Solomon GE; Hilgartner MW; Kutt H
Neurology; 1974 Oct; 24(10):920-4. PubMed ID: 4472231
[No Abstract] [Full Text] [Related]
35. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features of disseminated intravascular coagulation].
Lasch HG; Huth K; Heene DL; Müller-Berghaus G; Hörder MH; Janzarik H; Mittermayer C; Sandritter W
Dtsch Med Wochenschr; 1971 Apr; 96(17):715-27 passim. PubMed ID: 5279887
[No Abstract] [Full Text] [Related]
37. [Modern trends in the therapy of congenital and acquired coagulopathies].
Girolami A
Clin Ter; 1968 Jun; 45(5):469-93. PubMed ID: 4901167
[No Abstract] [Full Text] [Related]
38. Therapy of adult acute leukemia with daunorubicin and L-asparaginase.
Bodey GP; Hewlett JS; Coltman CA; Rodriguez V; Freireich EJ
Cancer; 1974 Mar; 33(3):626-30. PubMed ID: 4521886
[No Abstract] [Full Text] [Related]
39. L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.
Capizzi RL; Bertino JR; Skeel RT; Creasey WA; Zanes R; Olayon C; Peterson RG; Handschumacher RE
Ann Intern Med; 1971 Jun; 74(6):893-901. PubMed ID: 5281051
[No Abstract] [Full Text] [Related]
40. Coagulopathies.
Lewis JH; Spero JA; Hasiba U
Dis Mon; 1977 Jun; 23(9):1-64. PubMed ID: 326505
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
